Discovery slows down muscular dystrophy: University of Houston researchers target protein that can slow disease progression, improve muscle function

Duchenne muscular dystr the University of Houston College of Pharmacy sorder that occurs in one out of 3,600 male births.

The current standard of care for DMD is focused on reducing inflammation with corticosteroids, which modestly reduces disease progression, but Duchenne ous side effects. DMD cla DMD "summaryFeed_highLightText__NxlGi">Roy DMD< one an> 3,600 ass="summaryFe DMD highLightText__NxlGi">DMD Anirban early thirties pan class="summaryFeed_highLightText__NxlGi">the National Institutes of Health Kumar DMD Department of Pharmacological an kinase1 aceutical Sciences Philip Hargrove Endowed Professor Ashok Kumar DMD